8-K: OneMedNet Corporation Faces Nasdaq Delisting Risk Due to Market Value and Financial Deficiencies

OneMedNet Corporation has received a notification from Nasdaq regarding its failure to meet minimum market value and financial requirements for continued listing.

Summary

• OneMedNet Corporation received a letter from Nasdaq on October 8, 2024, stating that the company's Market Value of Listed Securities (MVLS) has fallen below the required $35 million for continued listing.
• The letter also noted that OneMedNet is not in compliance with Nasdaq rules requiring a minimum stockholders' equity of $2.5 million and a minimum of $500,000 of net income from continuing operations.
• The notification is not an immediate delisting notice, and the company has until April 7, 2025, to regain compliance.
• To regain compliance, OneMedNet's MVLS must close at or above $35 million for at least ten consecutive business days during the compliance period.
• If compliance is not achieved by April 7, 2025, Nasdaq may issue a delisting notice, which the company can appeal.
• OneMedNet intends to monitor its MVLS and explore options to resolve the deficiencies, but there is no guarantee of regaining compliance.

Sentiment

Score: 3

Explanation: The document indicates significant financial and compliance issues, creating a negative outlook for the company's stock. The risk of delisting is a major concern.

Positives

• The notification is not an immediate delisting notice, providing the company time to regain compliance.
• OneMedNet has the option to appeal any delisting determination to a hearings panel.

Negatives

• OneMedNet's MVLS is below the required $35 million for continued listing on Nasdaq.
• The company is also not in compliance with Nasdaq's minimum stockholders' equity and net income requirements.
• There is no assurance that the company will be able to regain or maintain compliance with Nasdaq listing standards.

Risks

• The company faces the risk of being delisted from Nasdaq if it fails to regain compliance by April 7, 2025.
• The company's stock price could be negatively impacted by the delisting risk.
• There is uncertainty regarding the company's ability to improve its financial performance and market valuation.

Future Outlook

The company intends to actively monitor its MVLS and evaluate options to regain compliance, but there is no guarantee of success.

Management Comments

• The Company intends to actively monitor the Companys MVLS between now and April 7, 2025, and may, if appropriate, evaluate available options to resolve the deficiency and regain compliance with the MVLS requirement.
• While the Company is exercising diligent efforts to maintain the listing of its securities on Nasdaq, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing standards.

Industry Context

This announcement highlights the challenges faced by smaller companies in maintaining listing requirements on major exchanges, particularly in volatile market conditions. It is not uncommon for companies to receive such notices, and the outcome often depends on their ability to improve financial performance and market perception.

Comparison to Industry Standards

• Many small-cap and micro-cap companies face similar challenges in maintaining Nasdaq listing compliance, especially those in the technology and healthcare sectors.
• Companies like Xometry (XMTR) and Vroom (VRM) have also faced delisting risks due to market capitalization issues, highlighting the broader trend of market volatility impacting smaller public companies.
• The required minimums for market capitalization, stockholders' equity, and net income are standard across Nasdaq and other exchanges, and OneMedNet's situation is not unique in this regard.

Stakeholder Impact

• Shareholders face the risk of potential delisting and a decline in stock value.
• Employees may experience uncertainty due to the company's financial challenges.
• Customers and suppliers may be concerned about the company's long-term viability.

Next Steps

• OneMedNet will monitor its MVLS between now and April 7, 2025.
• The company will evaluate options to resolve the deficiency and regain compliance.
• The company may appeal any delisting determination to a hearings panel.

Key Dates

Keywords

Nasdaq, delisting, compliance, market value, stockholders equity, net income, ONMD, MVLS